Back to results
US 2023/0416350 A1Published application
Tau-binding antibodies
AssigneeUcb Biopharma Srl
InventorsDAVID EDWARD ORMONDE KNIGHT, TERENCE SEWARD BAKER, DAVID JAMES MCMILLAN, ROBERT ANTHONY GRIFFIN, GEORGES MAIRET-COELLO, PATRICK DOWNEY, JEAN-PHILIPPE COURADE
Life of this patent
Estimating the term…
Abstract
The present invention relates to Tau-binding antibodies and binding fragments thereof.
Claims1
An isolated Tau-binding antibody or binding fragment thereof, wherein said Tau-binding antibody or binding fragment thereof comprises:
- a light chain variable region comprising a CDR1 selected from SEQ ID NO:
- 1, a CDR2 selected from SEQ ID NO:
- 2, and a CDR3 selected from SEQ ID NO:
- 3;
- and
- a heavy chain variable region comprising a CDR1 selected from SEQ ID NO:
- 4, a CDR2 selected from SEQ ID NO:
- 5, and/or a CDR3 selected from SEQ ID NO:
- 6.
6 more elements
Dependencies are inferred from the claim text.